Literature DB >> 9607955

P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.

P Anderle1, E Niederer, W Rubas, C Hilgendorf, H Spahn-Langguth, H Wunderli-Allenspach, H P Merkle, P Langguth.   

Abstract

The influence of cell culture conditions and previous drug exposure on P-glycoprotein (P-gp) expression levels in Caco-2 cells was determined. In this study, the expression of P-gp is demonstrated (i) visually by confocal laser scanning microscopy (CLSM), (ii) functionally by transport studies with substrates of the efflux pump, and (iii) quantitatively by flow cytometry (FCM) analysis using specific monoclonal antibodies (anti P-gp MRK 16 as an external antibody and P-GlycoCheck C219 as an internal antibody). Trypsinization of the cells after reaching confluence led to a decrease of P-gp expression levels, while trypsinization before reaching confluence led to an increase after long-term cultivation. Culturing the cells on polycarbonate filters did not elicit a significant change of P-gp expression over time in culture, whereas in plastic flasks (polystyrene) a decrease was detected. Using CLSM a strong fluorescence on the apical side of Caco-2 cell monolayers was observed, as a result of incubation with MRK 16 as primary and IgG Cy5 as secondary antibody. Previous drug exposure of the cells showed that verapamil, celiprolol, and vinblastine induced the P-gp expression, while metkephamid (MKA) decreased the P-gp expression level as compared to the control. Permeation studies consolidated the theory that P-gp is expressed in the Caco-2 cells examined. For talinolol and MKA, a higher transport from basolateral to apical side than from apical to basolateral could be measured. Incubation of the cell monolayer with MRK 16 reduced the secretion process to the apical side, but did not influence [3H]mannitol flux. Caco-2 cells seem to be a suitable cell line model for P-gp-mediated secretion studies. However, the variability of the P-gp expression requires careful control when this model is to be used in quantitative structure/secretion studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607955     DOI: 10.1021/js970372e

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  38 in total

1.  Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines.

Authors:  Pascale Anderle; Vera Rakhmanova; Katie Woodford; Noa Zerangue; Wolfgang Sadée
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.

Authors:  Kazutoshi Horie; Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

Review 3.  Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.

Authors:  Susan L Mercer; Andrew Coop
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Formation of multilayers in the caco-2 cell culture model: a confocal laser scanning microscopy study.

Authors:  B Rothen-Rutishauser; A Braun; M Günthert; H Wunderli-Allenspach
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

5.  An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.

Authors:  Brendan M Johnson; William N Charman; Christopher J H Porter
Journal:  AAPS PharmSci       Date:  2002

6.  Characterization and application of a vinblastine-selected CACO-2 cell line for evaluation of p-glycoprotein.

Authors:  Dennis A Laska; Jack O Houchins; Susan E Pratt; Jeffery Horn; Xialong Xia; Brenda R Hanssen; Daniel C Williams; Anne H Dantzig; Terry Lindstrom
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

7.  Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.

Authors:  Arik Dahan; Gordon L Amidon
Journal:  Pharm Res       Date:  2008-12-02       Impact factor: 4.200

8.  Transport characteristics of fexofenadine in the Caco-2 cell model.

Authors:  Niclas Petri; Christer Tannergren; David Rungstad; Hans Lennernäs
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

9.  Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

10.  Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.

Authors:  Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.